Wells Fargo & Company Valneva Se Put Options Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
13Shares Held
719KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.6 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il69.5KShares$509,4200.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$183,4110.06% of portfolio
-
Abc Arbitrage Sa Paris, I019.2KShares$141,0580.01% of portfolio
-
Morgan Stanley New York, NY2.73KShares$19,9740.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $507M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...